- Home
- ABP vs GELS Comparison
ABP vs GELS Comparison
Compare ABP & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- GELS
- Stock Information
- Founded
- ABP 2004
- GELS 2018
- Country
- ABP United States
- GELS Australia
- Employees
- ABP N/A
- GELS N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- GELS
- Sector
- ABP Health Care
- GELS
- Exchange
- ABP Nasdaq
- GELS NYSE
- Market Cap
- ABP 15.5M
- GELS 15.9M
- IPO Year
- ABP N/A
- GELS 2024
- Fundamental
- Price
- ABP $0.21
- GELS $1.88
- Analyst Decision
- ABP Strong Buy
- GELS
- Analyst Count
- ABP 1
- GELS 0
- Target Price
- ABP $4.00
- GELS N/A
- AVG Volume (30 Days)
- ABP 5.6M
- GELS 4.0M
- Earning Date
- ABP 08-18-2025
- GELS 02-15-2025
- Dividend Yield
- ABP N/A
- GELS N/A
- EPS Growth
- ABP N/A
- GELS N/A
- EPS
- ABP N/A
- GELS N/A
- Revenue
- ABP $183,000.00
- GELS $95,618.00
- Revenue This Year
- ABP N/A
- GELS N/A
- Revenue Next Year
- ABP N/A
- GELS N/A
- P/E Ratio
- ABP N/A
- GELS N/A
- Revenue Growth
- ABP 88.66
- GELS N/A
- 52 Week Low
- ABP $0.15
- GELS $0.77
- 52 Week High
- ABP $11.19
- GELS $5.50
- Technical
- Relative Strength Index (RSI)
- ABP N/A
- GELS N/A
- Support Level
- ABP N/A
- GELS N/A
- Resistance Level
- ABP N/A
- GELS N/A
- Average True Range (ATR)
- ABP 0.00
- GELS 0.00
- MACD
- ABP 0.00
- GELS 0.00
- Stochastic Oscillator
- ABP 0.00
- GELS 0.00
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.
About GELS GELTEQ LIMITED
Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.